ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Editas Medicine (EDIT) Technical (Analysis) Reports Editas Medicine ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Editas Medicine (EDIT)

Technical Analysis Report for USA stock EDIT Editas Medicine. Dated: 31 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock EDIT Editas Medicine then click here. or read Experts views on Editas Medicine or Forecast & share price targets of Editas Medicine

Editas Medicine Opened at 3.12 and Closed at: 3.06, which is -3.27% of previous session's close. It moved within a range of 3.03 and 3.14
The session was a Bearish session with an average volume of 2076000, which is -57.59% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.

A Golden cross was found 7 days back on mid term averages

A Golden cross was found 9 days back on mid term averages

Support for tomorrow is 2.99 and resistance for tomorrow is 3.1
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 3.01, 2.97 resistance for tomorrow's hourly charts is 3.12, 3.19

10 Day SMA for Editas Medicine (EDIT) is 3.12 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Editas Medicine (EDIT) is 2.98 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Editas Medicine (EDIT) is 2.98 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 2.97 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Editas Medicine is 2.6 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Editas Medicine is at 2.98 and 200 DMA is at 2.6, while 50 DMA and 100 DMA are at 2.98 and 2.97 respectively

Editas Medicine (EDIT) moving average of 20 SMA is at 2.98 and 20 EMA is at 3.01

Editas Medicine (EDIT) moving average of 50 SMA is at 2.98 and 50 EMA is at 2.94

Editas Medicine (EDIT) moving average of 100 SMA is at 2.97 and 100 EMA is at 2.9

Editas Medicine (EDIT) moving average of 200 SMA is at 2.6 and 200 EMA is at 2.67

Editas Medicine has performed better than Arcus Biosciences in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Penumbra Inc in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Baxter International in short term. Holding Editas Medicine could be a better choice for now!

Zymeworks Inc has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Zymeworks Inc, about 18.58% more returns!

Editas Medicine has performed better than Wave Life in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Sol Gel in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Petmed Express in short term. Holding Editas Medicine could be a better choice for now!

Minerva Neurosciences has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 2.4% more returns!

Moleculin Biotech has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Moleculin Biotech, about 45.63% more returns!

Editas Medicine has performed better than Microbot Medical in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Karyopharm Therapeutics in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Immuron in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Immutep in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Heron Therapeutics in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Gossamer Bio in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Genesis Healthcare in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Crispr Therapeutics in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Biogen Inc in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Biocryst Pharmaceuticals in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine Technical analysis of indicators

Price action analysis of Editas Medicine (EDIT) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Editas Medicine stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Editas Medicine in short term and the buy signal is strong.

Editas Medicine Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Editas Medicine in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Editas Medicine is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 3.15 and Editas Medicine EDIT stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Editas Medicine EDIT stock. Volume based technical analysis of Editas Medicine EDIT stock is negative.

Editas Medicine Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock EDIT Editas Medicine These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And EDIT Experts View which covers a lot of information including buying and selling signals

EDIT future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Editas Medicine or View Candle Stick Charts here

Chart Editas Medicine (EDIT)  Technical (Analysis) Reports Editas Medicine [

Videos related to: Editas Medicine (EDIT) Technical (Analysis) Reports Editas Medicine ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Editas Medicine (EDIT)  Technical (Analysis) Reports Editas Medicine [

 

Back to top